West Pharmaceutical Services Inc
Uždarymo kaina
SektoriusSveikatos priežiūra
335.99 2
Apžvalga
Akcijų kainos pasikeitimas
24 val.
Min
325
Max
336.26
Pajamos | 6.7M 139M |
|---|---|
Pardavimai | 40M 845M |
P/E Sektoriaus vid. | 44.079 49.712 |
Pelnas, tenkantis vienai akcijai | 2.13 |
Dividendų pajamingumas | 0.26 |
Pelno marža | 16.428 |
Darbuotojai | 10,800 |
EBITDA | 9M 219M |
Rekomendacijos | Stiprus pirkimas |
|---|---|
12 mėnesių prognozė | +13.13% upside |
Dividendų pajamingumas Sektoriaus vid. | 0.26% 2.36% |
|---|---|
Kitas uždarbis | 2026-07-23 |
Kitas dividendų mokėjimo data | 2026-08-05 |
Kita Ex Dividend data | 2026-07-29 |
Rinkos kapitalizacija | 3.3B 23B |
|---|---|
Ankstesnė atidarymo kaina | 333.99 |
Ankstesnė uždarymo kaina | 335.99 |
Naujienos nuotaikos
By Acuity
50%
50%
143 / 342 reitingas Healthcare
West Pharmaceutical Services Inc Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Apie bendrovę West Pharmaceutical Services Inc
West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.